Trials / Completed
CompletedNCT04579094
Prevalence and Risk Factors for the Carriage of Bacteria and Clostridioid in Elderly Dependent Persons
Prevalence and Risk Factors for the Carriage of Multi- and Highly Resistant Bacteria and Clostridioid Difficile Toxigenic in Residents and Healthcare Workers in Nursing Home (PREMS)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 492 (actual)
- Sponsor
- Centre Hospitalier Universitaire de Nīmes · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Brief summary : Very few studies have evaluated the prevalence of multi-drug resistant (MDR), highly resistant emerging bacteria and Clostridioides difficile toxinogenic (CDt) in residents and in healthcare workers (HCW) in nursing home (NH). Most of study were conducted in acute care services and were limited to specific bacterial species. Hypothesis : The carriage of MDR bacteria in resident may be a risk factor for an outbreak in NH or in healthcare facility. Primary outcome: The objective of this study is to estimate the prevalence for carriage of MDR bacteria and CDt in residents in NH. Secondary outcomes: * Estimate the prevalence for carriage of MDR bacteria and CDt toxigenic in HCW in NH. * Identify the risk factors for carriage of MDR bacteria and CDt in residents in nursing home * Identify the risk factors for carriage of MDR bacteria and CDt in healthcare workers in NH * Evaluate the presence of cross-transmission of MDR bacteria and CDt in one or several NH * Evaluate the association between the presence of cross-transmission of MDR bacteria and CDt in a NH and the management of infection control * Establishment a collection of stool samples
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Feces sampling at inclusion (J0) | Feces sampling at inclusion (J0) |
Timeline
- Start date
- 2022-05-25
- Primary completion
- 2024-09-30
- Completion
- 2024-09-30
- First posted
- 2020-10-08
- Last updated
- 2025-05-28
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04579094. Inclusion in this directory is not an endorsement.